Deep targeted sequencing of <i>TP53</i> in chronic lymphocytic leukemia: clinical impact at diagnosis and at time of treatment.

Haematologica · 2019 · PMC6442964 · PMID 30514802

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

VAF >10%), only high burden TP53 ab [including del(17p)] patients showed a trend for worse OS and significantly worse TFS compared to TP53 wt ( Figure 2A and B ) ( P =0.06 and P =0.01, respectively).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.